Autologous stem cell transplantation for systemic lupus erythematosus

Lupus

Volumn 13, Issue 3, 2004, Pages 168-176

  Jayne, David ^a   Passweg, Jacob ^b   Marmont, Alberto ^c   Farge, Dominique ^d   Zhao, Xiaowu ^e   Arnold, Renate ^f   Hiepe, Falk ^f   Lisukov, Igor ^g   Musso, Maurizio ^h   Ou Yang, Jian ⁱ   Marsh, Judith ^j   Wulffraat, Nico ^k   Besalduch, Juan ^l   Bingham, Sarah J ^m   Emery, Paul ^m   Brune, Mats ⁿ   Fassas, Athanasios ^o   Faulkner, Lawrence ^p   Ferster, Alina ^q   Fiehn, Christoph ^r   Fouillard, Loic ^s   Geromin, Antonella ^t   Greinix, Hildegard ^u   Rabusin, Marco ^v   Saccardi, Riccardo ^w   Schneider, Peter ^x   Zintl, Felix ^y   Gratwohl, Alois ^b   Tyndall, Alan ^b   more..

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY OF GENOA   (Italy)

^d SAINT LOUIS HOSPITAL   (France)

^e Peoples Hospital   (China)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g INSTITUTE OF CLINICAL IMMUNOLOGY   (Russian Federation)

^h La Maddelena Hospital ^*  (Italy)

ⁱ THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^j ST GEORGE S HOSPITAL   (United Kingdom)

^k UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^l HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^m LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

ⁿ SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^o G PAPANICOLAOU HOSPITAL   (Greece)

^p UNIVERSITY OF FLORENCE   (Italy)

^q HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

^r UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^s HÔPITAL SAINT ANTOINE   (France)

^t UNIVERSITY HOSPITAL OF UDINE   (Italy)

^u UNIVERSITY OF VIENNA   (Austria)

^v INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^w CAREGGI UNIVERSITY HOSPITAL   (Italy)

^x UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^y JENA UNIVERSITY HOSPITAL   (Germany)

more..

Author keywords

Registry; Stem cell; Systemic lupus erythematosus; Therapy; Transplantation

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; DNA ANTIBODY; DOUBLE STRANDED DNA; GRANULOCYTE COLONY STIMULATING FACTOR; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CELL SELECTION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; LYMPH NODE IRRADIATION; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; REGISTER; RELAPSE; REMISSION; SAFETY; SCHOOL CHILD; STEM CELL MOBILIZATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 11144357974     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203304lu525oa     Document Type: Article

References (49)

1. Hagelberg S, Lee Y, Bargman J et al. Longterm followup of childhood lupus nephritis. J Rheumatol 2002; 29: 26353-2642.
2. Bellomio V, Spindler A, Lucero E et al. Systemic lupus erythematosus: mortality and survival in Argentina. A multicenter study. Lupus 2000; 9: 377-381.
3. Donadio JV Jr, Hart GM, Bergstralh EJ et al. Prognostic determinants in lupus nephritis: a long-term clinicopathologic study. Lupus 1995; 4: 109-115.
4. Bono L, Cameron JS, Hicks JA. The very long-term prognosis and complications of lupus nephritis and its treatment. QJM 1999; 92: 11-218.
5. Illei GG, Takada K, Parkin D et al. Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies. Arthritis Rheum 2002; 46: 995-1002.
6. Boumpas DT, Austin HA, Vaughan EM et al. Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med 1993; 119: 366-369.
7. Besalduch J, Bargay J, Buades J et al. Autoimmune hemolytic anemia after treatment of severe systemic lupus erythematosus with high-dose chemotherapy and autotransplantation of selected peripheral hematopoictic progenitors. Haematologica 2003; 88: ECR01.
8. Brunner M, Greinix HT, Redlich K et al. Autologous blood stem cell transplantation in refractory systemic lupus erythematosus with severe pulmonary impairment: a case report. Arthritis Rheum 2002; 46: 1580-1584.
9. Traynor AE, Barr WG, Rosa RM et al. Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients. Arthritis Rheum 2002; 46: 2917-2923.
10. Zeng K, Peng XB, Sun J et al. [Transplantation of purified CD34+ stem cells from autologous peripheral blood for treatment of systemic lupus erythematosus]. Di Yi Jun Yi Da Xue Bao 2002; 22: 1052.
11. Wulffraat NM, Sanders EA, Kamphuis SS et al. Prolonged remission without treatment after autologous stem cell transplantation for refractory childhood systemic lupus erythematosus. Arthritis Rheum 2001; 44: 728-731.
12. Fouillard L, Gorin NC, Laporte JP et al. Control of severe systemic lupus erythematosus after high-dose immunusuppressive therapy and transplantation of CD34+ purified autologous stem cells from peripheral blood. Lupus 1999; 8: 320-323.
13. Musso M, Porretto F, Crescimanno A et al. Autologous peripheral blood stem and progenitor (CD34+) cell transplantation for systemic lupus erythematosus complicated by Evans syndrome. Lupus 1998; 7: 492-494.
14. Marmont AM, van Lint MT, Gualandi F et al. Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration. Lupus 1997; 6: 545-548.
15. Snowden JA, Patton WN, O'Donnell JL et al. Prolonged remission of longstanding systemic lupus erythematosus after autologous bone marrow transplant for non-Hodgkin's lymphoma. Bone Marrow Transplant 1997; 19: 1247-1250.
16. Ouyang J, Sun L, Yang Y. A pilot study in treatment of systemic lupus erythematosus by autologous bone marrow transplant. Zhonghua Nei Ke Za Zhi 2001; 40: 229-231.
17. Trysberg E, Lindgren I, Tarkowski A. Autologous stem cell transplantation in a case of treatment resistant central nervous system lupus. Ann Rheum Dis 2000; 59: 236-238.
18. Lisukov IA, Kulagin AD, Sizikova SA et al. High-dose immunosupression and stem cell transplantation in severe autoimmune diseases. Russ J Immunol 2001; 6: 187-192.
19. Rosen O, Thiel A, Massenkeil G et al. Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells. Arthritis Res 2000; 2: 327-336.
20. Schachna L, Ryan PF, Schwarer AP. Malignancy-associated remission of systemic lupus erythematosus maintained by autologous peripheral blood stem cell transplantation. Arthritis Rheum: 1998; 41: 2271-2272.
21. Meloni G, Capria S, Vignetti M et al. Blast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: regression of both diseases after autologous bone marrow transplantation. Blood 1997; 89: 4659.
22. Burt RK, Slavin S, Burns WH et al. Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure? Blood 2002; 99: 768-784.
23. Tyndall A. Immunoablation and haemopoietic stem cell transplantation for severe autoimmune disease with special reference to systemic lupus erythematosus. Lupus 2001; 10: 214-215.
24. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
25. Bombardier C, Gladman DD, Urowitz MB et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-640.
26. Rosen O, Hiepe F, Massenkeil G et al. Relapse of systemic lupus erythematosus. Lancet 2001; 357: 807-808.
27. Marmont AM. Lupus: tinkering with haematopoietic stem cells. Lupus 2001; 10: 769-774.
28. Pavletic SZ, Klassen LW, Pope R et al. Treatment of relapse after autologous L blood stem cell transplantation for severe rheumatoid arthritis. J Rheumatol 2001; 64: 28-31.
29. Papadaki HA, Boumpas DT, Gibson FM et al. Increased apoptosis of bone marrow CD34(+) cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus. Br J Haematol 2001; 115: 167-174.
30. Burt RK, Fassas A, Snowden J et al. Collection of hematopoietic stem cells from patients with autoimmune diseases. Bone Marrow Transplant 2001; 28: 1-12.
31. Austin HA, Balow JE. Treatment of lupus nephritis. Semin Nephrol 2000; 20: 265-276.
32. Moore J, Brooks P, Milliken S et al. A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis Rheum 2002; 46: 2301-2309.
33. Korbet SM, Lewis EJ, Schwartz MM et al. Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J m J Kidney Dis 2000; 35: 904-914.
34. Cook RJ, Gladman DD, Pericak D et al. Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity. J Rheumatol 2000; 27: 1892-1895.
35. Tyndall A, Fassas A, Passweg J et al. Autologous haematopoietic stem cell transplants for autoimmune disease-feasibility and transplant-related mortality. Bone Marrow Transplant 1999; 24: 729-734.
36. Shaughnessy PJ, Ririe DW, Omstein DL et al. Graft failure in a patient with systemic lupus erythematosus (SLE) treated with high-dose in1munosuppression and autologous stem cell rescue. Bone Marrow Transplant 2001; 27: 221-224.
37. Liu H, Ozaki K, Matsuzaki Y et al. Suppression of haematopoiesis by IgG autoantibodies from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1995; 100: 480-485.
38. Marques JA, Rhim H, Distenfeld A. Inhibition of hematopoiesis by a plasma factor in a case of aplastic anemia associated with systemic lupus erythematosus. P R Health Sci J 1995; 14: 293-296.
39. Coles AJ, Wing M, Smith S et al. Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. Lancet 1999; 354: 1691-1695.
40. Hartert A, Willenbacher W, Gunzelmann S et al. Successful treatment of thrombocytopenia and hemolytic anemia with IvIG in a patient with lupus-like syndrome after mismatched related PBSCT. Bone Marrow Transplant 2001; 27: 337-340.
41. Steinbach WJ, Sandborg CI. Development of systemic lupus erythematosus following autologous bone marrow transplant for acute lymphocytic leukemia. J Rheumatol 2001; 28: 1467-1468.
42. Conference synopsis: hematopoietic stem cell therapy in autoimmune diseases, October 2001 Biol Blood Marrow Transplant 2002; 8: 407-411.
43. Euler HH, Marmont AM, Bacigalupo A et al. Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation. Blood 1996; 88: 3621-3625.
44. Petry F, Botto M, Holtappels R et al. Reconstitution of the. complement function in Clq-deficient (Clqa-/-) mice with wild-type bone marrow cells. J Immunol 2001; 167: 4033-4037.
45. El Badri NS, Wang BY, Steele A et al. Successful prevention of autoimmune disease by transplantation of adequate number of fully allogeneic hematopoietic stem cells. Transplantation 2000; 70: 870-877.
46. Ishida T, Inaba M, Hisha H et al. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MIP-lpr/lpr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor. J Immunol 1994; 152: 3119-3127.
47. Bao L, Haas M, Boackle SA et al. Transgenic expression of a soluble complement inhibitor protects against, renal disease and promotes survival in MRL/lpr mice. J Immunol 2002; 168: 3601-3607.
48. Petri M, Jones RI, Brodsky RA. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus. Arthritis Rheum 2003; 48: 166-173.
49. Burt RK, Marmont A, Arnold R et al. Development of a phase III trial of hematopoietic stem cell transplantation for systemic lupus erythematosus. Bone Marrow Transplant 2003; 32 (Suppl 1): S49-51.